The effective shelf creates immediate overhang risk. Monitor for insider selling filings (Form 4) and volume spikes. The stock may face downward pressure as selling stockholders begin to exit positions. No company catalyst offsets this dilution risk.
Price Chart
Executive Summary
The SEC declared effective Sensei Biotherapeutics' S-3 shelf registration on June 12, 2026, registering up to 24,868,028 common shares for resale by selling stockholders (Faeth acquisition consideration and PIPE investors). The company receives no proceeds, but the effectiveness unlocks immediate potential overhang as existing holders can now sell shares into the market.
Key Facts
- Effectiveness date: June 12, 2026 (filed June 15).
- S-3 registers 24,868,028 shares for resale by selling stockholders.
- Company will not receive any proceeds from the resale.
- Shares are issuable upon conversion of Series B Preferred Stock issued in the Faeth acquisition and a concurrent private placement.
- Prior S-3/A filings (April 28, June 2, June 10) indicated the same share count and no capital raise for the company.
Financial Impact
Potential overhang of up to 24.9M shares (significant relative to $17M market cap); no new capital raised.
Risk Factors
- Selling stockholders may begin disposing shares, pressuring the stock price.
- Large registered share count relative to market cap could amplify selling impact.
- Lack of company capital raise means no offsetting positive catalyst.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-001978 |
| Document: 9999999995-26-001978-index.html | 9999999995-26-001978 |
| Document: 9999999995-26-001978.txt | 9999999995-26-001978 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jun 16, 2026 19w ago | 3 | $13.86 | awaiting T+5 | — | — |
Jun 15, 2026 19w ago | 8-K | $13.04 | awaiting T+5 | — | — |
Jun 15, 2026 19w ago | EFFECT | $13.04 | awaiting T+5 | — | — |
Jun 10, 2026 19w ago | S-3/A | $10.79 $13.85 | ▲ +28.36% | ▲ +27.93% | — |
Jun 10, 2026 19w ago | 8-K | $10.79 $13.85 | ▲ +28.36% | ▲ +27.93% | — |
Jun 2, 2026 21w ago | 10-K/A | $16.10 $12.63 | ▼ −21.53% | ▼ −18.56% | — |
Jun 2, 2026 21w ago | S-3/A | $16.10 $12.63 | ▲ +21.53% | ▲ +18.56% | — |
Jun 1, 2026 21w ago | Insider Cluster | $16.10 $12.63 | ▲ +21.53% | ▲ +18.56% | — |
May 22, 2026 22w ago | DEFA14A | $16.47 $19.79 | ▲ +20.16% | ▲ +19.07% | — |
May 22, 2026 22w ago | 8-K | $16.47 $19.79 | ▲ +20.16% | ▲ +19.07% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers